Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
UK Supreme Court case
|
| gptkbp:application |
gptkb:Warner-Lambert_Company_LLC
|
| gptkbp:citation |
gptkb:[2019]_1_All_ER_161
gptkb:[2019]_RPC_6 |
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:date |
2018-11-14
|
| gptkbp:fullName |
gptkb:Warner-Lambert_Company_LLC_v_Generics_(UK)_Ltd_t/a_Mylan_and_another
|
| https://www.w3.org/2000/01/rdf-schema#label |
[2018] UKSC 49
|
| gptkbp:judge |
gptkb:Lord_Mance
gptkb:Supreme_Court_of_the_United_Kingdom gptkb:Lord_Sumption gptkb:Lord_Reed gptkb:Lord_Briggs gptkb:Lord_Hodge |
| gptkbp:legalIssue |
sufficiency of disclosure
infringement of second medical use patents |
| gptkbp:legalSubject |
gptkb:US_patent
pharmaceutical patents |
| gptkbp:neutralCitation |
gptkb:[2018]_UKSC_49
|
| gptkbp:response |
gptkb:Actavis_Group_PTC_EHF
gptkb:Generics_(UK)_Ltd_t/a_Mylan |
| gptkbp:bfsParent |
gptkb:Lee_v._Ashers_Baking_Company_Ltd
|
| gptkbp:bfsLayer |
6
|